Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BCE Emergis was a prominent Canadian health technology company that specialized in electronic commerce and health informatics. The company provided a comprehensive suite of services designed to automate administrative and clinical processes, including electronic claims processing, pharmacy management systems, and health record integration. By connecting healthcare providers, insurers, and government bodies, BCE Emergis aimed to improve the efficiency and security of health information exchange. In 2008, the company was acquired by TELUS for approximately $763 million CAD, serving as the cornerstone for the creation of TELUS Health. Today, its legacy technologies continue to support the digital infrastructure of the Canadian healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BCE Emergis.